Walgreen pharmacies are back online after earlier reporting that many stores couldn't fill prescriptions due to a database failure, Dow Jones said.» Read More
Hi all. Here's a report that ran on CNBC-TV today that might be of interest. It's money manager Mike Koskuba of Victory Capital Management on stocks he thinks have a great upside coming to them--and stock holders. Now, these are not necessarily for you to add to your contest picks (or your personal portfolio) and you might to get tremendous gains, but they are some stocks to think about.
Pharmacy benefit manager Express Scripts reported a 28% rise in quarterly profit Monday that beat Wall Street expectations, helped by increased use of generic drugs, and raised its profit forecast.
Texas' Attorney General said he filed a court action against CVS/Caremark, after finding customer records including personal information in a trash dumpster behind one of the chain's Texas stores.
Mattel, CVS, Intuitive Surgical and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Saks, Acadia Pharma, Geron, Harley Davidson, Walgreen and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
The guys go behind the headlines and give you their take on... Dell's delay... CVS vs. Walgreen... and more. Find out where they see fast money.
Caremark Rx shareholders on Friday approved a roughly $24 billion takeover offer from drug-store chain CVS bringing to an end a months-long takeover fight with Express Scripts for the rival pharmacy benefits manager.
Okay--here's our current celebrity standings as of the market close on Thursday, 3/15. Overall their approach is still a lot more conservative than the majority of our non-celeb leaders - more stable companies and purchases spread across multiple stocks, and it might end up being a race to see who can lose the least. But that's probably to be expected....
Shareholders of CVS, the No. 2 U.S. drugstore chain, approved the company's $23.9 billion plan to buy pharmacy benefits manager Caremark Rx.
Influential proxy advisory firm Institutional Shareholder Services said on Tuesday it recommends that Caremark Rx shareholders support a takeover proposal from drugstore chain CVS, reversing its previous stance.
In an exclusive interview with CNBC's David Faber, Express Scripts' CEO George Paz said his nearly $27 billion bid for Caremark Rx is his "best and only" offer unless the rival pharmacy-benefits manager opens its financial records for review.
In an exclusive interview with CNBC's David Faber, CVS Chairman and Chief Executive Officer Tom Ryan said he won't raise his bid for Caremark.
Caremark Rx said on Friday a second request for information from U.S. antitrust regulators into a takeover offer from Express Scripts is evidence the bid from the rival pharmacy benefit manager may not be able to be completed.
CVS sweetened its $23.9 billion takeover bid for Caremark on Thursday with an increaseddividend, calling its newest proposal its "best and final" offer for the pharmacy-benefits manager.
Right now, the best move for investors is to find stocks that made it through the sell-off without a scratch. Luckily, Cramer’s here to help.
Callers question Cramer about CVS, Medtronic, JPMorgan Chase and more...
Pharmacy benefits manager and takeover target Caremark Rx on Tuesday reported higher earnings and net revenue for the fourth quarter, driven by an increase in retail and mail sales.
Caremark attorney Robert Thornton presented a document that he said showed that Express Scripts considered killing the CVS deal to be a successful outcome even if its own offer was rejected.
A Delaware judge ordered Caremark Rx to delay a shareholder vote on a proposed acquisition by CVS just hours after the drugstore operator tripled the special cash dividend it proposes to pay as part of the deal.
CtW said it would be urging Caremark shareholders, including the pension funds and investment managers, to vote against the deal.